Arestocaine HCL en es it fr

Arestocaine HCL Brand names, Arestocaine HCL Analogs

Arestocaine HCL Brand Names Mixture

  • No information avaliable

Arestocaine HCL Chemical_Formula


Arestocaine HCL RX_link

Arestocaine HCL fda sheet

Arestocaine_HCL FDA

Arestocaine HCL msds (material safety sheet)

Arestocaine_HCL MSDS

Arestocaine HCL Synthesis Reference

No information avaliable

Arestocaine HCL Molecular Weight

129.164 g/mol

Arestocaine HCL Melting Point

223-226 oC

Arestocaine HCL H2O Solubility

Freely soluble as HCl salt

Arestocaine HCL State


Arestocaine HCL LogP


Arestocaine HCL Dosage Forms

Extended release tablet (500 mg or 1000 mg)

Arestocaine HCL Indication

For use as an adjunct to diet and exercise to improve glycemic control in adult patients (18 years and older) with type 2 diabetes.

Arestocaine HCL Pharmacology

Metformin is an antihyperglycemic agent, which improves glucose tolerance in patients with type 2 diabetes, lowering both basal and postprandial plasma glucose. Metformin is not chemically or pharmacologically related to any other classes of oral antihyperglycemic agents. Unlike sulfonylureas, metformin does not produce hypoglycemia in either patients with type 2 diabetes or normal subjects and does not cause hyperinsulinemia. With metformin therapy, insulin secretion remains unchanged while fasting insulin levels and daylong plasma insulin response may actually decrease.

Arestocaine HCL Absorption

Absorbed over 6 hours, bioavailability is 50 to 60% under fasting conditions. Food delays absorption.

Arestocaine HCL side effects and Toxicity

Acute oral toxicity (LD50): 350 mg/kg [Rabbit]. It would be expected that adverse reactions of a more intense character including epigastric discomfort, nausea, and vomiting followed by diarrhea, drowsiness, weakness, dizziness, malaise and headache might be seen.

Arestocaine HCL Patient Information

Arestocaine HCL Organisms Affected

Humans and other mammals